Hong Kong Biotech Stocks Rally on 7 August 2026; Zai Lab, Yaojie Ankang, Pharmaron Lead
Hong Kong's innovative drug sector strengthened during trading on 7 August 2026, with most stocks posting solid gains. Zai Lab led the advance, rising over 12%, while Yaojie Ankang-B gained over 10% and Pharmaron climbed over 5%. WuXi AppTec, Ascletis Pharma, BeiGene, WuXi Biologics, and WuXi XDC each rose over 3%. The broad-based rally lifted the overall sector, and trading activity increased. Investor sentiment remained positive as the biotech segment continued its upward trend.
Hong Kong's innovative drug sector strengthened with volatility during trading on 7 August 2026. As of intraday, Zai Lab's share price rose over 12%, Yaojie Ankang-B gained over 10%, and Pharmaron advanced over 5%. WuXi AppTec, Ascletis Pharma, BeiGene, WuXi Biologics, and WuXi XDC each rose over 3%. The performance of these stocks lifted the overall sector, and market trading activity improved.